KR20210065855A - Method for preparing compound K using red ginseng, enzymes and natural products - Google Patents
Method for preparing compound K using red ginseng, enzymes and natural products Download PDFInfo
- Publication number
- KR20210065855A KR20210065855A KR1020200155911A KR20200155911A KR20210065855A KR 20210065855 A KR20210065855 A KR 20210065855A KR 1020200155911 A KR1020200155911 A KR 1020200155911A KR 20200155911 A KR20200155911 A KR 20200155911A KR 20210065855 A KR20210065855 A KR 20210065855A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- red ginseng
- enzyme
- natural product
- present
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 48
- 229930014626 natural product Natural products 0.000 title claims abstract description 38
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 35
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 35
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 67
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 229940088598 enzyme Drugs 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 12
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 240000000599 Lentinula edodes Species 0.000 claims description 11
- 241000408747 Lepomis gibbosus Species 0.000 claims description 11
- 235000020236 pumpkin seed Nutrition 0.000 claims description 11
- 244000144725 Amygdalus communis Species 0.000 claims description 10
- 235000020224 almond Nutrition 0.000 claims description 10
- 108010059892 Cellulase Proteins 0.000 claims description 9
- 229920002488 Hemicellulose Polymers 0.000 claims description 9
- 229940106157 cellulase Drugs 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 229940059442 hemicellulase Drugs 0.000 claims description 4
- 108010002430 hemicellulase Proteins 0.000 claims description 4
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 235000013376 functional food Nutrition 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 229930182494 ginsenoside Natural products 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 235000017709 saponins Nutrition 0.000 description 6
- 235000001715 Lentinula edodes Nutrition 0.000 description 5
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 5
- 235000011437 Amygdalus communis Nutrition 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940092309 pumpkin seed extract Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- -1 mixing red ginseng Natural products 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 231100000279 safety data Toxicity 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008362 succinate buffer Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/23—Removal of unwanted matter, e.g. deodorisation or detoxification by extraction with solvents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 홍삼, 효소 및 천연물 추출물을 혼합하는 단계를 포함하는 컴파운드 K의 제조방법 등에 관한 것이다.The present invention relates to a method for producing a compound K, including mixing red ginseng, an enzyme and a natural product extract.
진세노사이드는 홍삼에 포함된 사포닌으로, Rg1, Rb1 및 Rg3 등을 함유하고 있어 면역력 증진, 신경 안정, 암 예방 억제 등에 효능이 뛰어나지만 천연 홍삼 사포닌은 흡수가 잘 안되는 문제가 있다. Ginsenoside is a saponin contained in red ginseng. It contains Rg1, Rb1, and Rg3, so it is effective in enhancing immunity, stabilizing nerves, and inhibiting cancer prevention. However, natural red ginseng saponin has a problem of poor absorption.
사포닌의 주요 성분이 효과를 나타내려면 '컴파운드 K'(compound K)로 전환되어야 하는데 이러한 컴파운드 K는 홍삼의 유효성분인 사포닌이 장내미생물에 의해 당이 제거되어 생성되는 물질이며, 컴파운드 K로 전환되지 못한 인삼사포닌은 체외로 배출된다. 그러나, 연령별, 성별로 진세노사이드(인삼의 사포닌 흡수율)을 측정한 식약처 자료를 보면, 실험대상자의 25%가 장내 미생물의 효소 비활성화로 인해 진세노사이드를 온전히 혈액으로 흡수하지 못함이 확인되었다. 또한, 천연 홍삼 제품은 진세노사이드가 체내에서 컴파운드케이로 전환되어 흡수되기까지 약 10시간 이상이 소요되며, 그 과정에서 많은 부분이 흡수되지 못하고 체외로 배출된다.In order for the main component of saponin to have an effect, it must be converted into 'compound K'. This compound K is a substance produced by removing sugar from saponin, an active ingredient of red ginseng, by intestinal microbes, and is not converted to compound K. Unsatisfactory ginseng saponins are excreted from the body. However, according to the Ministry of Food and Drug Safety data, which measured ginsenosides (saponin absorption rate of ginseng) by age and sex, it was confirmed that 25% of the test subjects did not fully absorb ginsenosides into the blood due to enzyme inactivation of intestinal microorganisms. . In addition, in natural red ginseng products, it takes about 10 hours or more for ginsenosides to be converted into compound K in the body and absorbed, and in the process, many parts are not absorbed and are discharged outside the body.
이런 측면에서 이미 외부에서 가공처리를 완료하여, 개인의 대사 기능에 관계없이 홍삼의 유효성분을 흡수할 수 있는 형태로 전환시키는 컴파운드 K 제조기술은 매우 의미있는 것이나 이에 대한 연구는 아직 미흡한 실정이다.In this respect, the compound K manufacturing technology that has already completed external processing and converts the active ingredient of red ginseng into a form that can be absorbed regardless of an individual's metabolic function is very meaningful, but research on it is still insufficient.
본 발명의 발명자는 홍삼에 효소 및 천연물 추출물을 함께 처리하는 경우 효소 단독 처리 또는 천연물 단독 처리에 비해 컴파운드 K 수득량이 현저히 증가하는 것을 확인하여 본 발명을 완성하였다.The inventors of the present invention completed the present invention by confirming that when red ginseng is treated with an enzyme and a natural product extract, the compound K yield is significantly increased compared to an enzyme alone treatment or a natural product alone treatment.
이에 본 발명은 홍삼 추출물, 효소 및 천연물 추출물을 혼합하는 단계를 포함하는 컴파운드 K의 제조방법을 제공한다.Accordingly, the present invention provides a method for producing a compound K comprising mixing a red ginseng extract, an enzyme and a natural product extract.
본 발명은 홍삼 추출물, 효소 및 천연물 추출물을 혼합하는 단계를 포함하는 컴파운드 K의 제조방법에 있어서, 상기 효소는 셀룰레이즈(Cellulase), 베타-글루코시다아제 (β-glucosidase) 및 헤미셀룰레이즈 (hemicellulose)로 이루어진 군으로부터 선택된 1 이상인 것이고, 상기 천연물은 표고버섯, 아몬드 및 호박씨로 이루어진 군으로부터 선택된 1 이상인 것인, 컴파운드 K의 제조방법을 제공한다.The present invention provides a method for preparing compound K comprising mixing a red ginseng extract, an enzyme and a natural product extract, wherein the enzyme is cellulose (Cellulase), beta-glucosidase (β-glucosidase) and hemicellulose (hemicellulose) ) is at least one selected from the group consisting of, and the natural product is at least one selected from the group consisting of shiitake mushrooms, almonds and pumpkin seeds.
본 발명의 일 구현예로, 상기 홍삼 추출물은 에탄올 추출물일 수 있다.In one embodiment of the present invention, the red ginseng extract may be an ethanol extract.
본 발명의 일 구현예로, 상기 에탄올은 60 내지 80 %(v/v)의 에탄올 수용액일 수 있다.In one embodiment of the present invention, the ethanol may be an aqueous solution of 60 to 80% (v/v) ethanol.
본 발명의 일 구현예로, 상기 홍삼 추출물은 70 내지 90℃ 조건으로 추출된 것일 수 있다.In one embodiment of the present invention, the red ginseng extract may be extracted under 70 to 90 ℃ conditions.
본 발명의 일 구현예로, 상기 홍삼 추출물은 30 내지 120분 동안 추출될 수 있다.In one embodiment of the present invention, the red ginseng extract may be extracted for 30 to 120 minutes.
본 발명의 일 구현예로, 상기 천연물 추출물은 상기 홍삼 추출물, 효소 및 천연물 추출물의 총 부피에 대하여 30 내지 40 %(v/v)로 포함될 수 있다.In one embodiment of the present invention, the natural product extract may be included in an amount of 30 to 40% (v/v) with respect to the total volume of the red ginseng extract, the enzyme and the natural product extract.
본 발명의 일 구현예로, 상기 천연물 추출물은 천연물 추출물의 상등액일 수 있다.In one embodiment of the present invention, the natural product extract may be a supernatant of the natural product extract.
본 발명의 일 구현예로, 상기 상등액은 하기의 단계를 포함하는 방법으로 제조되는 것일 수 있다.In one embodiment of the present invention, the supernatant may be prepared by a method comprising the following steps.
a) 천연물을 분쇄하는 단계;a) grinding the natural product;
b) 상기 a)단계의 분쇄물이 0.01 내지 1 g/ml 농도가 되도록 용매를 가하는 단계;b) adding a solvent so that the pulverized product of step a) has a concentration of 0.01 to 1 g/ml;
c) 상기 b)단계 결과물을 1 내지 10℃에서 12 내지 36시간 동안 침지시키는 단계; 및c) immersing the resultant of step b) at 1 to 10° C. for 12 to 36 hours; and
d) 상기 c)단계 결과물에서 상등액을 수득하는 단계.d) obtaining a supernatant from the result of step c).
본 발명의 일 구현예로, 상기 b)단계에서 용매는 증류수 또는 완충용액일 수 있다.In one embodiment of the present invention, the solvent in step b) may be distilled water or a buffer solution.
본 발명의 일 구현예로, 상기 효소는 셀룰레이즈(Cellulase), 베타-글루코시다아제 (β-glucosidase) 및 헤미셀룰레이즈 (hemicellulose)를 포함할 수 있다.In one embodiment of the present invention, the enzyme may include cellulose (Cellulase), beta-glucosidase (β-glucosidase) and hemicellulose (hemicellulose).
본 발명의 일 구현예로, 상기 천연물은 호박씨를 포함할 수 있다.In one embodiment of the present invention, the natural product may include pumpkin seeds.
본 발명은 홍삼 추출물, 효소 및 천연물 추출물을 혼합하는 단계를 포함하는 컴파운드 K의 제조방법 등에 관한 것으로, 본 발명의 방법에 의하면 효소 단독 사용시에 비해 컴파운드 K의 생성량이 현저히 증가함을 확인하였는바, 홍삼 관련 건강기능식품 등의 제조에 유용하게 이용될 수 있을 것으로 기대된다.The present invention relates to a method for producing compound K, including a step of mixing a red ginseng extract, an enzyme and a natural product extract, and the method of the present invention confirms that the amount of compound K is significantly increased compared to when the enzyme is used alone, It is expected to be usefully used in the manufacture of health functional foods related to red ginseng.
도 1은 실험조건별 컴파운드 K 생성량을 확인하기 위한 얇은 막 크로마토그래피 검사 결과를 나타낸 것이다.
도 2는 실험조건별 컴파운드 K 생성량을 그래프로 나타낸 것이다.1 shows the results of thin film chromatography to confirm the amount of compound K produced by each experimental condition.
2 is a graph showing the amount of compound K generated by experimental conditions.
본 발명의 발명자는 홍삼 추출물에 효소 및 천연물 추출물을 함께 처리하는 경우 효소 단독 처리 또는 천연물 단독 처리에 비해 컴파운드 K 수득량이 현저히 증가하는 것을 확인하여 본 발명을 완성하였다.The inventor of the present invention has completed the present invention by confirming that the yield of compound K is significantly increased compared to the enzyme alone treatment or the natural product alone treatment when the red ginseng extract is treated with the enzyme and the natural product extract.
이에 본 발명은 홍삼 추출물, 효소 및 천연물 추출물을 혼합하는 단계를 포함하는 컴파운드 K의 제조방법에 있어서, 상기 효소는 셀룰레이즈(Cellulase), 베타-글루코시다아제 (β-glucosidase) 및 헤미셀룰레이즈 (hemicellulose)로 이루어진 군으로부터 선택된 1 이상인 것이고, 상기 천연물은 표고버섯, 아몬드 및 호박씨로 이루어진 군으로부터 선택된 1 이상인 것인, 컴파운드 K의 제조방법을 제공한다.Accordingly, the present invention provides a method for preparing compound K comprising mixing a red ginseng extract, an enzyme and a natural product extract, wherein the enzyme is cellulase, beta-glucosidase, and hemicellulose ( hemicellulose), and the natural product is at least one selected from the group consisting of shiitake mushrooms, almonds and pumpkin seeds.
본 발명에서 컴파운드 K(Compound K)란 진세노사이드의 최종 대사물질이자 생리활성 물질로 하기 화학식 1로 표시된다. 컴파운드 K는 그 제조가 상당히 까다로워 대량으로 제조하기 어려운 것으로 알려져 있다.In the present invention, compound K (Compound K) is a final metabolite and physiologically active substance of ginsenoside and is represented by the following formula (1). Compound K is known to be difficult to manufacture in large quantities because it is quite difficult to manufacture.
[화학식 1][Formula 1]
본 발명에서 상기 홍삼은 가공하지 않은 홍삼 자체 또는 홍삼을 물리적 또는 화학적으로 가공한 것을 모두 포함하는 개념이다.In the present invention, the red ginseng is a concept including both unprocessed red ginseng itself or those obtained by physically or chemically processing red ginseng.
본 발명에서 추출물이란 특정 물질을 추출하여 수득한 물질이다. 예를 들어 상기 추출물은 홍삼 또는 천연물을 용매에 침지한 다음, 저온, 상온 또는 가온 상태에서 일정시간동안 추출하여 수득한 액상성분, 상기 액상성분으로부터 용매를 제거하여 수득한 고형분 등의 결과물을 의미할 수 있으나 이에 제한되지는 않고, 추출액, 추출액의 희석액 또는 농축액, 추출액을 건조하여 얻어지는 건조물, 또는 이들 조정제물 또는 정제물을 모두 포함할 수 있다. 상기 용매는 물, C1 내지 C4의 알코올, 헥산(Hexane) 및 그의 혼합물로 구성된 군으로부터 선택되는 하나 이상의 용매일 수 있으나 이에 제한되는 것은 아니다.In the present invention, an extract is a substance obtained by extracting a specific substance. For example, the extract refers to a result such as a liquid component obtained by immersing red ginseng or natural product in a solvent and then extracting it for a certain period of time at low temperature, room temperature or warming state, and a solid obtained by removing the solvent from the liquid component However, the present invention is not limited thereto, and may include an extract, a diluted or concentrated solution of the extract, a dried product obtained by drying the extract, or all of these crude products or purified products. The solvent may be one or more solvents selected from the group consisting of water, C 1 to C 4 alcohols, hexane, and mixtures thereof, but is not limited thereto.
본 발명에서 상기 홍삼 추출물은 에탄올 추출물일 수 있다.In the present invention, the red ginseng extract may be an ethanol extract.
본 발명에서 상기 에탄올은 60 내지 80 %(v/v)의 에탄올 수용액일 수 있으며 바람직하게는 70 %(v/v) 에탄올 수용액일 수 있다.In the present invention, the ethanol may be 60 to 80% (v/v) aqueous ethanol solution, preferably 70% (v/v) ethanol aqueous solution.
본 발명에서 상기 홍삼 추출물은 70 내지 90℃ 조건으로 추출된 것일 수 있으며,바람직하게는 72, 75 또는 85℃ 더욱 바람직하게는 72℃ 조건으로 추출된 것일 수 있다.In the present invention, the red ginseng extract may be extracted under 70 to 90 ℃ conditions, preferably at 72, 75 or 85 ℃, more preferably 72 ℃ conditions may be extracted.
본 발명에서 상기 홍삼 추출물은 30 내지 120분 동안 추출된 것일 수 있으며, 바람직하게는 60분 동안 추출된 것일 수 있다.In the present invention, the red ginseng extract may be extracted for 30 to 120 minutes, preferably for 60 minutes.
본 발명에서 상기 효소는 셀룰레이즈(Cellulase), 베타-글루코시다아제 (β-glucosidase) 및 헤미셀룰레이즈 (hemicellulose)로 이루어진 군으로부터 선택된 1 이상의 효소일 수 있으며, 바람직하게는 셀룰레이즈(Cellulase), 베타-글루코시다아제 (β-glucosidase) 및 헤미셀룰레이즈 (hemicellulase) 혼합 효소일 수 있다. 상기 효소의 제형상 제한은 없으나 바람직하게는 고형, 파우더 또는 액상 효소일 수 있다.In the present invention, the enzyme may be one or more enzymes selected from the group consisting of cellulase, beta-glucosidase, and hemicellulose, preferably cellulase, It may be a beta-glucosidase (β-glucosidase) and hemicellulase (hemicellulase) mixed enzyme. There is no limitation on the formulation of the enzyme, but it may preferably be a solid, powder or liquid enzyme.
본 발명에서 상기 천연물은 표고버섯, 아몬드 및 호박씨로 이루어진 군으로부터 선택된 1 이상일 수 있으며, 바람직하게는 호박씨일 수 있다. 상기 표고버섯, 아몬드 및 호박씨는 원물 또는 이를 물리적 또는 화학적으로 가공한 것일 수 있다.In the present invention, the natural product may be at least one selected from the group consisting of shiitake mushrooms, almonds and pumpkin seeds, and preferably pumpkin seeds. The shiitake mushrooms, almonds and pumpkin seeds may be raw materials or a physical or chemical processing thereof.
본 발명에서 상기 천연물 추출물은 상기 홍삼 추출물, 효소 및 천연물 추출물의 총 부피에 대하여 30 내지 40 %(v/v)로 포함될 수 있고 바람직하게는 35 %(v/v)로 포함될 수 있다.In the present invention, the natural product extract may be included in an amount of 30 to 40% (v/v), preferably 35% (v/v), based on the total volume of the red ginseng extract, enzyme and natural product extract.
본 발명에서 상기 천연물 추출물은 천연물 추출물의 상등액(supernatant)일 수 있다.In the present invention, the natural product extract may be a supernatant of the natural product extract.
본 발명에서 상기 상등액은 하기의 단계를 포함하는 방법으로 제조될 수 있다:In the present invention, the supernatant may be prepared by a method comprising the following steps:
a) 천연물을 분쇄하는 단계;a) grinding the natural product;
b) 상기 a)단계의 분쇄물이 0.01 내지 1 g/ml 농도가 되도록 용매를 가하는 단계;b) adding a solvent so that the pulverized product of step a) has a concentration of 0.01 to 1 g/ml;
c) 상기 b)단계 결과물을 1 내지 10 ℃에서 12 내지 36시간 동안 침지시키는 단계; 및c) immersing the resultant of step b) at 1 to 10° C. for 12 to 36 hours; and
d) 상기 c)단계 결과물에서 상등액을 얻는 단계.d) obtaining a supernatant from the result of step c).
바람직하게, 상기 b)단계에서 분쇄물의 농도는 0.1 g/ml일 수 있으며, 상기 c)단계에서 침지는 4 ℃에서 24시간 동안 수행될 수 있다.Preferably, the concentration of the pulverized product in step b) may be 0.1 g/ml, and the immersion in step c) may be performed at 4° C. for 24 hours.
본 발명에서 상기 b)단계에서 용매는 증류수 또는 완충용액일 수 있다. 상기 용매의 pH 제한은 없으나 예시로서 pH 4 내지 10, 바람직하게는 pH 5 내지 9, 더욱 바람직하게는 pH 6 내지 8, 가장 바람직하게는 pH 7일 수 있다.In the present invention, the solvent in step b) may be distilled water or a buffer solution. There is no limitation on the pH of the solvent, but as an example, it may be pH 4 to 10, preferably pH 5 to 9, more preferably pH 6 to 8, and most preferably
또한, 상기 완충용액은 본 발명에서 사용되는 효소의 활성(적절한 활성 pH는 4 내지 4.5)을 해치지 않는 범위의 것이면 제한없이 사용할 수 있고, 이는 당해 분야의 통상의 기술자라면 공지된 완충용액을 적절하게 선택 가능하다. 예를 들어, 상기 완충용액은 시트레이트 완충용액 (Citrate buffer), 숙시네이트 완충용액 (Succinate buffer), 말레이트 완충용액 (Maleate buffer) 또는 아세테이트 완충용액 (Acetate buffer) 일 수 있으며, 바람직하게는 Tris-HCl 완충용액 일 수 있다.In addition, the buffer solution can be used without limitation as long as it does not impair the activity of the enzyme used in the present invention (proper active pH is 4 to 4.5), and a known buffer solution is appropriately used by those skilled in the art. It is selectable. For example, the buffer may be a citrate buffer, a succinate buffer, a maleate buffer, or an acetate buffer, preferably Tris -HCl buffer solution may be used.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 하기 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred examples are presented to help the understanding of the present invention. However, the following examples are only provided for easier understanding of the present invention, and the contents of the present invention are not limited by the following examples.
<실시예><Example>
<실시예 1: 재료 및 준비><Example 1: Materials and Preparation>
홍삼은 금산도매시장의 홍미삼을 구입하여 사용하였으며 해당 홍삼은 스탠 믹서기를 사용하여 일정 크기의 메쉬로 분쇄하였다. 천연물인 아몬드는 ㈜ 넥스푸드에서 (미국산) 표고버섯은 로컬 마트에서 (국산), 호박씨는 ㈜ 열매마을에서 (중국산) 각각 구입하였다. 식용효소인 Sumizyme AC 및 플러스자임 2000은 비전 바이오켐에서 구입하였다. 얇은 막 크로마토그래피 플레이트는 Merck 사 aluminum 제품을 사용하였다. 기타 본 발명에서 사용한 시약 및 기구는 모두 상업적으로 구매 가능하다.Red ginseng purchased from the Geumsan Wholesale Market was used, and the red ginseng was ground into a mesh of a certain size using a Stan mixer. Almonds, a natural product, were purchased from Nexfood Co., Ltd. (USA), shiitake mushrooms were purchased from a local mart (Korea), and pumpkin seeds were purchased from Fruit Village Co., Ltd. (China). Edible enzymes Sumizyme AC and Pluszyme 2000 were purchased from Vision Biochem. For the thin film chromatography plate, Merck's aluminum product was used. All other reagents and instruments used in the present invention are commercially available.
<실시예 2: 컴파운드 K의 제조><Example 2: Preparation of compound K>
홍삼추출물 제조를 위해 홍미삼 50g을 121℃의 온도와 15lb psi에서 15분간 고압멸균한 뒤 70% 에탄올 1L에 침지시켰다. 상기 침지된 홍미삼은 85℃에서 리히비 냉각기를 사용하여 1 시간가량 추출되었다. 추출된 용액은 회전식증발농축기를 사용하여 에탄올을 제거하였으며, 남은 농축액을 본 발명의 홍삼 추출물로 이용하였다.For the preparation of red ginseng extract, 50 g of red ginseng was autoclaved at a temperature of 121° C. and 15 lb psi for 15 minutes and then immersed in 1 L of 70% ethanol. The immersed red rice ginseng was extracted at 85° C. for about 1 hour using a Lihibi cooler. Ethanol was removed from the extracted solution using a rotary evaporator, and the remaining concentrate was used as the red ginseng extract of the present invention.
본 발명의 천연물 추출물 제조를 위해 20 mM Tris-HCl(pH 7.0)에 20g의 표고버섯, 아몬드 또는 호박씨를 스탠 믹서기를 사용하여 일정 크기의 메쉬로 물리적으로 분쇄하여 4℃에서 24시간 침지시킨 후, 13,000 rpm에서 10분간 원심분리하여 상등액을 채취하고 3 um 마이크로 필터를 사용하여 불순물을 제거하여 반응에 사용하였다.For the preparation of the natural extract of the present invention, 20 g of shiitake, almond or pumpkin seeds in 20 mM Tris-HCl (pH 7.0) were physically crushed into a mesh of a certain size using a Stan mixer and immersed at 4° C. for 24 hours, The supernatant was collected by centrifugation at 13,000 rpm for 10 minutes, and impurities were removed using a 3 um micro filter and used in the reaction.
효소액은 최종 반응액(홍삼 추출물, 효소 및 천연물 추출물의 총합)의 v/v %가 되도록 미리 증류수에 녹여서 균질화시킨 후 반응 직전에 홍삼 추출물에 투입하였다.The enzyme solution was dissolved in distilled water in advance so as to be v/v % of the final reaction solution (the sum of red ginseng extract, enzyme and natural product extract) and homogenized, and then added to the red ginseng extract just before the reaction.
구체적으로, 반응액은 구연산 등을 사용하여 pH를 4~5 사이로 조정하여 효소반응을 최적화시켰다. 효소액인 Sumizyme AC 7% v/v(상기 홍삼추출물, 효소 및 천연물 추출물의 총 부피 기준, 이하동일)와 천연물 추출액(표고, 아몬드 또는 호박씨 추출물) 35% v/v를 섞어 vortexing하여 균질화 하였으며, 천연물 추출액을 사용하지 않을 경우에는 동일량의 증류수를 사용하여 혼합하였다. 상기 준비된 혼합물을 홍삼 추출물에 넣고 진탕배양기에서 50℃의 온도로 72시간동안 반응시켰다. 반응이 종료된 반응액은 즉시 95℃에서 10분간 중탕하여 효소를 비활성화시켰다. 이후 4,000 rpm에서 5분간 원심분리하여 상등액을 취하고 3 um 마이크로 필터를 통해 불순물을 여과하였다.Specifically, the reaction solution was adjusted to pH between 4 and 5 using citric acid to optimize the enzymatic reaction. The enzyme solution,
<실시예 3: 컴파운드 K 함량 분석><Example 3: Analysis of Compound K Content>
TLC 분석은 상기 반응이 종료된 반응액 중 1000 ul를 취해 물포화 부탄올 400 ul과 혼합하여 vortexing한 후 13,000 rpm에서 1분간 원심분리하여 층분리를 확인하고 상등액을 취하여 TLC 플레이트에 20 ul씩 점적하였다. TLC 전개액은 클로로포름 : 메탄올 : 물을 65 : 35 : 10의 비율로 혼합한 전개용매를 사용하였으며 전개조에 전개액을 100 ml가량 넣고 점적된 박층을 배치한 후 밀폐하여 일정 높이까지 전개시킨 다음, 박층을 전개조에서 꺼내 말린 후 10%의 황산을 도포한 뒤 110℃에서 건조하여 컴파운드 K의 유무룰 확인하였다.For TLC analysis, 1000 ul of the reaction solution after the reaction was completed was mixed with 400 ul of water-saturated butanol, vortexed, and then centrifuged at 13,000 rpm for 1 minute to confirm layer separation. The supernatant was taken and dripped on a TLC plate by 20 ul. . For the TLC developing solution, a developing solvent mixed with chloroform:methanol:water in a ratio of 65:35:10 was used. About 100 ml of the developing solution was put into the developing tank, a thin layer was placed, sealed, and developed to a certain height. After the thin layer was taken out of the developing tank and dried, 10% sulfuric acid was applied, and then dried at 110° C. to check the presence or absence of compound K.
진세노사이드 분석은 금산국제인삼약초연구소에 의뢰하였으며 시료를 헥산 및 메탄올에 1:1로 가하여 3시간동안 진탕 추출하고, 층이 분리되면 감압농축하여 70% 메탄올에 완전이 용해시킨 후 0.45 uM 필터에 여과하였다. HPLC 장비는 agilent 사의 장비를 이용하였고, 컬럼은 C18 역상 컬럼을 사용하여, 시료용액 10 ul를 증류수 및 아세토니트릴 이동상에 1 ml / min의 속도로 주입하고 203 nm 파장에서 검출하는 방법을 수행하였다.Ginsenoside analysis was commissioned by Geumsan International Ginseng Herbal Research Institute, and the sample was added 1:1 to hexane and methanol, extracted with shaking for 3 hours, and when the layers were separated, concentrated under reduced pressure and completely dissolved in 70% methanol, followed by a 0.45 uM filter was filtered. Agilent's equipment was used for HPLC equipment, and a C18 reversed-phase column was used for the column, and 10 ul of the sample solution was injected into distilled water and acetonitrile mobile phase at a rate of 1 ml / min, and detection at a wavelength of 203 nm was performed.
그 결과, Sumizyme AC 및 천연물(표고, 아몬드, 호박씨) 추출액을 혼합하여 이용한 경우 다른 군에 비하여 현저히 높은 컴파운드 K 제조가 가능하며 특히, 천연물 추출물로 호박씨 추출물을 이용한 경우 가장 높은 컴파운드 K 제조가 가능함을 확인하였다(하기 표 1, 도 1 및 도 2 참조).As a result, when Sumizyme AC and natural product (shiitake, almond, pumpkin seed) extract are mixed and used, significantly higher compound K can be produced compared to other groups, and in particular, when pumpkin seed extract is used as a natural extract, the highest compound K can be produced. It was confirmed (see Table 1, Figures 1 and 2 below).
Claims (11)
In the method for producing a compound K comprising mixing a red ginseng extract, an enzyme and a natural product extract, the enzyme is cellulase (Cellulase), beta-glucosidase (β-glucosidase) and hemicellulase (hemicellulase) consisting of It is at least one selected from the group, and the natural product is at least one selected from the group consisting of shiitake mushrooms, almonds and pumpkin seeds.
The method of claim 1, wherein the red ginseng extract is an ethanol extract.
The method of claim 2, wherein the ethanol is an aqueous ethanol solution of 60 to 80% (v/v).
The method of claim 1, wherein the red ginseng extract is extracted under 70 to 90°C conditions.
The method of claim 1, wherein the red ginseng extract is extracted for 30 to 120 minutes.
The method of claim 1, wherein the natural extract is included in an amount of 30 to 40% (v/v) based on the total volume of the red ginseng extract, the enzyme and the natural extract.
The method of claim 1, wherein the natural product extract is a supernatant of the natural product extract.
a) 천연물을 분쇄하는 단계;
b) 상기 a)단계의 분쇄물이 0.01 내지 1 g/ml 농도가 되도록 용매를 가하는 단계;
c) 상기 b)단계 결과물을 1 내지 10℃에서 12 내지 36시간 동안 침지시키는 단계; 및
d) 상기 c)단계 결과물에서 상등액을 수득하는 단계.
The method of claim 7, wherein the supernatant is prepared by a method comprising the steps of:
a) grinding the natural product;
b) adding a solvent so that the pulverized product of step a) has a concentration of 0.01 to 1 g/ml;
c) immersing the resultant of step b) at 1 to 10° C. for 12 to 36 hours; and
d) obtaining a supernatant from the result of step c).
The method of claim 8, wherein the solvent in step b) is distilled water or a buffer solution.
According to claim 1, wherein the enzyme is cellulase (Cellulase), beta- glucosidase (β-glucosidase) and hemicellulose (hemicellulose) will include, the method for producing compound K.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190154500 | 2019-11-27 | ||
KR20190154500 | 2019-11-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210065855A true KR20210065855A (en) | 2021-06-04 |
KR102494672B1 KR102494672B1 (en) | 2023-02-06 |
Family
ID=76391883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200155911A KR102494672B1 (en) | 2019-11-27 | 2020-11-19 | Method for preparing compound K using red ginseng, enzymes and natural products |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102494672B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100945586B1 (en) * | 2009-07-14 | 2010-03-08 | (주)새롬바이오 | Method for preparing of fermented ginseng or fermented red ginseng containing ginsenoside metabolites fermented by phellinus linteus having various physiological activity |
KR20100076524A (en) * | 2008-12-26 | 2010-07-06 | 중앙대학교 산학협력단 | Functional ginseng preparation using almond extract and process for thereof |
JP2016094414A (en) * | 2014-11-12 | 2016-05-26 | シージェイ チェイルジェダン コーポレーションCj Cheiljedang Corporation | Pharmaceutical composition and health functional food containing red ginseng concentrate having enhanced compound k for preventing and treating non-alcoholic fatty liver disease |
KR20200121196A (en) | 2019-04-15 | 2020-10-23 | 주식회사 리바이오 | Method for Preparation of Bioconverted Red Ginseng with Enhanced compound K content |
-
2020
- 2020-11-19 KR KR1020200155911A patent/KR102494672B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100076524A (en) * | 2008-12-26 | 2010-07-06 | 중앙대학교 산학협력단 | Functional ginseng preparation using almond extract and process for thereof |
KR100945586B1 (en) * | 2009-07-14 | 2010-03-08 | (주)새롬바이오 | Method for preparing of fermented ginseng or fermented red ginseng containing ginsenoside metabolites fermented by phellinus linteus having various physiological activity |
JP2016094414A (en) * | 2014-11-12 | 2016-05-26 | シージェイ チェイルジェダン コーポレーションCj Cheiljedang Corporation | Pharmaceutical composition and health functional food containing red ginseng concentrate having enhanced compound k for preventing and treating non-alcoholic fatty liver disease |
KR20200121196A (en) | 2019-04-15 | 2020-10-23 | 주식회사 리바이오 | Method for Preparation of Bioconverted Red Ginseng with Enhanced compound K content |
Non-Patent Citations (2)
Title |
---|
Biosci. Biotechnol. Biochem., Vol. 77, pp. 1138-1140 (2013.)* * |
김의영, 석사학위논문, 서울대학교 (2013.)* * |
Also Published As
Publication number | Publication date |
---|---|
KR102494672B1 (en) | 2023-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108653417B (en) | Method for extracting sorbus nigromaculata and extract thereof | |
CN101077864A (en) | Vaccinnium vitis-idaea extract, preparation method and application thereof | |
CN106132425B (en) | Composition containing citrus seed extract, food, drug, and method for producing composition containing citrus seed extract | |
WO2005016362A1 (en) | A ginseng preparation using vinegar and process for thereof | |
KR20050109269A (en) | A ginseng preparation using vinegar and process for thereof | |
US11104631B1 (en) | Isopentenyl chalcone compound and preparation method thereof | |
CN108265092A (en) | A kind of mushroom oligosaccharides and preparation method with excellent antioxidant activity | |
JP5888763B2 (en) | Fermented buckwheat extract | |
KR20150057084A (en) | Method for extracting maysin and bioactive compounds with high yield from corn silk | |
KR102494672B1 (en) | Method for preparing compound K using red ginseng, enzymes and natural products | |
JP2011037800A (en) | Blood glucose level elevation inhibitor and food material for preventing diabetes by using apios blossom | |
WO2022142561A1 (en) | Quaternary ammonium salt alkaloid compound in noni enzyme, preparation method therefor and application thereof | |
CN109880864A (en) | The enzyme process method for integrated extraction of function polysaccharide and procyanidine in a kind of longan peel | |
KR101872590B1 (en) | A method for separating polysaccharides using ultra high-pressure and enzymes from by-product of red ginseng | |
CN105001284B (en) | A kind of purple spring wheat wheat bran anthocyanin extracting method | |
RU2613294C1 (en) | Method for producing melanin from sunflower husks | |
CN103087119B (en) | One grows flax Cerebrosides compound and extraction and separation method thereof | |
US11186533B2 (en) | Chalcone compound and preparation method thereof | |
KR20140090863A (en) | Method for preparing red panax ginseng extract with enhanced nonpolar ginsenosides contents | |
KR101416669B1 (en) | Ginseng prosapogenin high concentration containing ginseng berry preparation using sonication and process for thereof | |
KR101416673B1 (en) | Ginseng prosapogenin high concentration containing ginseng flower preparation using sonication and process for thereof | |
KR20100076524A (en) | Functional ginseng preparation using almond extract and process for thereof | |
KR100444394B1 (en) | Preparation Method of Ginseng Extract with High Amount of Saponine Content | |
KR100615854B1 (en) | Continuously extraction and purification of phenolic compounds and pectin from asian pear peel | |
CN104450824A (en) | Method for preparing manninotriose and manninotetraose by taking mung beans as raw material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |